{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:54:52Z","timestamp":1789167292179,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/ftd.0b013e31821fb197","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T02:52:15Z","timestamp":1307415135000},"page":"387-392","source":"Crossref","is-referenced-by-count":36,"title":["Posaconazole Plasma Concentrations in Critically Ill Patients"],"prefix":"10.1097","volume":"33","author":[{"given":"John","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Rudham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1439-0507.2006.01296.x","article-title":"Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.","volume":"49","author":"Groll","year":"2006","journal-title":"Mycoses"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/AAC.45.3.857-869.2001","article-title":"Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.","volume":"45","author":"Petraitiene","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1128\/AAC.47.9.2788-2795.2003","article-title":"Pharmacokinetics, safety and tolerability of oral posaconazole administered in single and multiple doses in healthy adults.","volume":"47","author":"Courtney","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.50.2.658-666.2006","article-title":"Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.","volume":"50","author":"Ullmann","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/AAC.48.3.804-808.2004","article-title":"Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men.","volume":"48","author":"Courtney","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00003495-200868070-00008","article-title":"Posaconazole: a review of its use in the treatment of invasive fungal infections.","volume":"68","author":"Frampton","year":"2008","journal-title":"Drugs"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/AAC.01178-08","article-title":"Pharmacokinetics of posaconazole administered orally or by nasogastric tube in healthy volunteers.","volume":"53","author":"Dodds Ashley","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1592\/phco.27.12.1627","article-title":"Pharmacokinetics of oral posaconazole in allogeneic haematopoietic stem cell transplant recipients with graft-versus-host disease.","volume":"27","author":"Krishna","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/AAC.00472-06","article-title":"Effects of age, gender and race\/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers.","volume":"51","author":"Sansone-Parsons","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1185\/030079907X187937","article-title":"Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.","volume":"23","author":"Krishna","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-151-2-200907210-00018","article-title":"Posaconazole-induced topiramate toxicity.","volume":"151","author":"Marriott","year":"2009","journal-title":"Ann Int Med"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.","volume":"48","author":"Bruggemann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1592\/phco.27.6.825","article-title":"Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.","volume":"27","author":"Sansone-Parsons","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1185\/03007990802644209","article-title":"Effects of oral posaconazole on the pharmacokinetics of sirolimus.","volume":"25","author":"Moton","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.00663-08","article-title":"Intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole at steady-state in healthy subjects.","volume":"53","author":"Conte","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.00240-09","article-title":"Posaconazole therapeutic drug monitoring: a reference laboratory experience.","volume":"53","author":"Thompson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/clpt.2010.64","article-title":"Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma.","volume":"88","author":"Jang","year":"2010","journal-title":"Clin Pharm Ther"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.hrtlng.2004.02.001","article-title":"Effect of gastrointestinal motility and feeding tube site on aspiration risk in critically ill patients: a review.","volume":"33","author":"Metheny","year":"2004","journal-title":"Heart Lung"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/AAC.01468-08","article-title":"Effect of Rifampicin a potent inducer of drug-metabolising enzymes on the pharmacokinetics of raltegravir.","volume":"53","author":"Wenning","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-3-20210129","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1469-0691.2009.02821.x","article-title":"Candidaemia with uncommon candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.","volume":"15","author":"Chen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R24-3-20210129","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2141.2007.06812.x","article-title":"Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients.","volume":"139","author":"Barnes","year":"2007","journal-title":"Br J Haematol"},{"key":"R25-3-20210129","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00003246-199506000-00010","article-title":"Enteral nutrition in the critically ill patient: a prospective survey.","volume":"23","author":"Heyland","year":"1995","journal-title":"Crit Care Med"},{"key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00134-004-2511-2","article-title":"Parenteral vs enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle.","volume":"31","author":"Simpson","year":"2004","journal-title":"Int Care Med"},{"key":"R27-3-20210129","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00199879","article-title":"Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole.","volume":"46","author":"Zimmermann","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"R28-3-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MCC.0b013e3280523a88","article-title":"Gastrointestinal motility and prokinetics in the critically ill.","volume":"13","author":"Chapman","year":"2007","journal-title":"Curr Opin Crit Care"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e31821fb197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:30:05Z","timestamp":1786044605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201108000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31821fb197","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}